image description

Tag: GSK

New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis

December 17, 2019 The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive clinical trial results in treating lupus nephritis (LN), a common complication of lupus causing inflammation of the kidneys that can result in end-stage kidney disease. Called BLISS-LN, this Phase 3 trial is the largest one […] Read More

The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals

November 12, 2019 The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation (NKF) on a free course for healthcare professionals about ways to better diagnose, monitor and treat patients with systemic lupus erythematosus (SLE) and lupus nephritis. The online course is critically important because as the community […] Read More

Updates in Lupus Clinical Research from the LUPUS 2019 Meeting

April 11, 2019 The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS 2019.  These studies continue to push our way forward toward new and improved treatments to help the lupus community. There’s a Silver Lining in New Belimumab Results Jim Oates, MD, Medical University of South Carolina, […] Read More

Join Us at Lupus Research and Advocacy Conference

Find Out How Lupus Research Can Transform Lives at a Free Conference and Cocktail Reception  Learn about the newest advances in lupus research and how to advocate for more research funding from the federal government, to support future discoveries. Wednesday, July 17, 2019 5:45 PM Reception 7:00 PM Panel Discussion iHeartMedia 125 W 55th Street […] Read More

Benlysta Approved for Children 5-Years and Up

April 26, 2019 We are very pleased to share news from GlaxoSmithKline (GSK) that intravenous Benlysta (belimumab) was approved by the U.S. Food and Drug Administration to treat children with lupus who are five years old or above. The approval was based on data from the ‘PLUTO’ study testing over one year the effectiveness and […] Read More

Exagen Diagnostics Collaborates with GSK

Jan. 25, 2018 Source: Press release, Exagen Diagnostics GSK and Exagen Diagnostics announced their collaboration that aims to make it easier for doctors to diagnose lupus. “GSK will raise awareness of Exagen’s AVISE diagnostic and monitoring tests, which have been shown to help diagnose and monitor SLE, to a select group of healthcare professionals.” Read More
Stay informed about events, research developments, and ways you can help. Sign up for updates